PURPOSE: To determine dosimetric parameters associated with osteoradionecrosis (ORN) in oropharyngeal cancer (OPC) patients in the IMRT era. MATERIAL AND METHODS: Subsequent to institutional review board approval, we identified ORN in OPC patients treated with IMRT from 2002 to 2013. 1:2 case-control matching was implemented. Mandibular dose-volume histograms (DVH) were extracted. Dosimetric parameters were compared using non-parametric stats. Recursive partitioning analysis (RPA) was done to identify DVH correlates of ORN. RESULTS: 68 ORN cases and 131 controls were matched. Median follow-up was 41months and median time to development of ORN was 16months. Mandibular mean dose was significantly higher in the ORN cohort (48.1 vs 43.6Gy, p<0.0001). However, the maximum dose was not statistically different. DVH bins from V35 to V73 were all significantly higher in the ORN cohort compared with controls (p<0.0006). Two DVH parameters were identified in RPA analysis, V43 and V58. The majority (81%) of ORN cases were observed with both V44≥42% and V58≥25%. CONCLUSIONS: Our data demonstrate that a wide range of DVH parameters in the intermediate and high beam path were all significantly higher in ORN patients. Mandibular V44<42% and V58<25% represent reasonable DVH constraints for IMRT plan acceptability, when tumor coverage is not compromised.
PURPOSE: To determine dosimetric parameters associated with osteoradionecrosis (ORN) in oropharyngeal cancer (OPC) patients in the IMRT era. MATERIAL AND METHODS: Subsequent to institutional review board approval, we identified ORN in OPCpatients treated with IMRT from 2002 to 2013. 1:2 case-control matching was implemented. Mandibular dose-volume histograms (DVH) were extracted. Dosimetric parameters were compared using non-parametric stats. Recursive partitioning analysis (RPA) was done to identify DVH correlates of ORN. RESULTS: 68 ORN cases and 131 controls were matched. Median follow-up was 41months and median time to development of ORN was 16months. Mandibular mean dose was significantly higher in the ORN cohort (48.1 vs 43.6Gy, p<0.0001). However, the maximum dose was not statistically different. DVH bins from V35 to V73 were all significantly higher in the ORN cohort compared with controls (p<0.0006). Two DVH parameters were identified in RPA analysis, V43 and V58. The majority (81%) of ORN cases were observed with both V44≥42% and V58≥25%. CONCLUSIONS: Our data demonstrate that a wide range of DVH parameters in the intermediate and high beam path were all significantly higher in ORN patients. Mandibular V44<42% and V58<25% represent reasonable DVH constraints for IMRT plan acceptability, when tumor coverage is not compromised.
Authors: Merav A Ben-David; Maximiliano Diamante; Jeffrey D Radawski; Karen A Vineberg; Cynthia Stroup; Carol-Anne Murdoch-Kinch; Samuel R Zwetchkenbaum; Avraham Eisbruch Journal: Int J Radiat Oncol Biol Phys Date: 2007-02-22 Impact factor: 7.038
Authors: Daniel T Chang; Pamela R Sandow; Christopher G Morris; Rachel Hollander; Lauren Scarborough; Robert J Amdur; William M Mendenhall Journal: Head Neck Date: 2007-06 Impact factor: 3.147
Authors: Charles A Baron; Musaddiq J Awan; Abdallah S R Mohamed; Imad Akel; David I Rosenthal; G Brandon Gunn; Adam S Garden; Brandon A Dyer; Laurence Court; Parag R Sevak; Esengul Kocak-Uzel; Clifton D Fuller Journal: J Appl Clin Med Phys Date: 2014-01-08 Impact factor: 2.102
Authors: Souptik Barua; Hesham Elhalawani; Stefania Volpe; Karine A Al Feghali; Pei Yang; Sweet Ping Ng; Baher Elgohari; Robin C Granberry; Dennis S Mackin; G Brandon Gunn; Katherine A Hutcheson; Mark S Chambers; Laurence E Court; Abdallah S R Mohamed; Clifton D Fuller; Stephen Y Lai; Arvind Rao Journal: Front Artif Intell Date: 2021-04-09
Authors: Yunze Yang; Olivia M Muller; Satomi Shiraishi; Matthew Harper; Adam C Amundson; William W Wong; Lisa A McGee; Jean-Claude M Rwigema; Steven E Schild; Martin Bues; Mirek Fatyga; Justin D Anderson; Samir H Patel; Robert L Foote; Wei Liu Journal: Front Oncol Date: 2022-03-03 Impact factor: 6.244
Authors: Lisanne V van Dijk; Abdelrahman A Abusaif; Jillian Rigert; Mohamed A Naser; Katherine A Hutcheson; Stephen Y Lai; Clifton D Fuller; Abdallah S R Mohamed Journal: Int J Radiat Oncol Biol Phys Date: 2021-06-10 Impact factor: 8.013
Authors: Benjamin D Lovin; Mike Hernandez; Hunter Elms; Jonathan S Choi; Nathan R Lindquist; Amy C Moreno; Marc-Elie Nader; Paul W Gidley Journal: Laryngoscope Date: 2021-07-20 Impact factor: 2.970